TRC120038, a Novel Dual AT(1)/ET(A) Receptor Blocker for Control of Hypertension, Diabetic Nephropathy, and Cardiomyopathy in ob-ZSF1 Rats

In hypertensive subjects, angiotensin II and endothelin participate in a manner involving closely interwoven pathways in increasing blood pressure (BP) and inducing end organ damage. The primary objective of this study was to determine the effect of TRC120038, a novel dual AT(1)/ET(A) receptor block...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanan, Anookh, Gupta, Ram, Dubey, Amita, Jagtap, Vikrant, Mandhare, Appaji, Gupta, Ramesh C., Chauthaiwale, Vijay, Dutt, Chaitanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253485/
https://www.ncbi.nlm.nih.gov/pubmed/22235363
http://dx.doi.org/10.4061/2011/751513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253485/
https://www.ncbi.nlm.nih.gov/pubmed/22235363
http://dx.doi.org/10.4061/2011/751513

Ejemplares similares